| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |